Vir Biotechnology, Inc.
VIRDrugs in Pipeline
10
Phase 3 Programs
4
Upcoming Catalysts
4
Next Catalyst
Aug 5, 2026
4wMarket Overview
Stock performance and key metrics
4 upcoming, 0 past
How VIR's past catalysts played out
Tobevibart
Viral Hepatitis
Elebsiran
Viral Hepatitis
VIR-7831 (sotrovimab)
Covid19
Bulevirtide
Viral Hepatitis
NRTI
Hepatitis D, Chronic
VIR-2218
Hepatitis B, Chronic
pegylated interferon-alfa 2a
Chronic Hepatitis B
VIR-5818
Locally Advanced or Metastatic HER2-Expressing Cancers
Sotrovimab (Gen1)
Covid19
VIR-3434
Hepatitis B, Chronic
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Tobevibart | Phase 3 | Viral Hepatitis | - | - |
Elebsiran | Phase 3 | Viral Hepatitis | - | - |
VIR-7831 (sotrovimab) | Phase 3 | Covid19 | - | - |
Bulevirtide | Phase 3 | Viral Hepatitis | - | - |
NRTI | Phase 2 | Hepatitis D, Chronic | - | - |
VIR-2218 | Phase 2 | Hepatitis B, Chronic | - | - |
pegylated interferon-alfa 2a | Phase 2 | Chronic Hepatitis B | - | - |
VIR-5818 | Phase 2 | Locally Advanced or Metastatic HER2-Expressing Cancers | - | - |
Sotrovimab (Gen1) | Phase 2 | Covid19 | - | - |
VIR-3434 | Phase 2 | Hepatitis B, Chronic | - | - |
Viral Hepatitis
3 drugs in this indication
Covid19
2 drugs in this indication
Chronic Hepatitis B
2 drugs in this indication
Hepatitis B, Chronic
2 drugs in this indication
Hepatitis D, Chronic
1 drug in this indication
Locally Advanced or Metastatic HER2-Expressing Cancers
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Vir Biotechnology, Inc.'s drug pipeline?→
CatalystAlert tracks 10 drug candidates in Vir Biotechnology, Inc.'s (VIR) pipeline across Phase 3, Phase 2. Its lead program is Tobevibart (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Vir Biotechnology, Inc.'s next FDA catalyst?→
Vir Biotechnology, Inc.'s (VIR) next tracked catalyst is a Earnings expected August 5, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track VIR biotech catalysts?→
Add VIR to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Vir Biotechnology, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.